Related Experiment Video
Updated: Oct 30, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Feasibility and Safety of Continuous Glucose Monitoring in Infants at Risk of Hypoglycemia in a Rooming-in Setting
Kryštof Tabery1, Ladislava Doležalová2, Miloš Černý3
1Department of Neonatology, Motol University Hospital, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Insights
Continuous glucose monitoring (CGM) in newborns is safe for clinical and developmental outcomes in a rooming-in setting. This pilot study found no adverse neurodevelopmental effects in infants monitored with real-time CGM.
Area of Science:
- Neonatal Medicine
- Medical Technology
- Pediatric Neurology
Background:
- Current neonatal hypoglycemia screening relies on intermittent blood sampling.
- Continuous glucose monitoring (CGM) offers improved glucose control and patient comfort.
- Previous CGM use in neonates was limited to intensive care or blinded settings.
Purpose of the Study:
- To evaluate the safety and feasibility of real-time continuous glucose monitoring (CGM) in a rooming-in setting for newborns.
- To assess the clinical and neurodevelopmental outcomes of infants monitored with CGM from birth.
Main Methods:
- CGM devices were applied within the first two hours of life.
- Low glucose readings were confirmed with blood glucose measurements to prevent overtreatment.
- Neurodevelopmental evaluations were conducted at 24 months using Bayley scales.
Main Results:
- 44 infants were enrolled in the pilot study.
- CGM identified three infants with verified hypoglycemia.
- No infants demonstrated neurodevelopmental deficits below 2 standard deviations on Bayley scales, with median scores in cognitive, language, and motor domains.
Conclusions:
- Real-time CGM in a rooming-in environment is clinically safe and does not negatively impact neurodevelopmental outcomes.
- Further randomized trials are necessary to confirm superiority in long-term outcomes.
Abstract:
Background:Screening of neonatal hypoglycemia uses currently intermittent blood sampling. Continuous glucose monitoring (CGM) allows for tighter glucose control and better comfort for newborns and parents. CGM has previously been used in intensive care setting or blinded to clinicians. Our pilot study uses CGM in real time in rooming-in setting. Methods: CGM was attached within first two hours of life. Low glucose readings were verified to prevent overtreatment. Pairs of sensor readings and corresponding blood glucose measurements were assessed retrospectively. Neurodevelopmental evaluation was performed at 24 months. Results: 44 infants were enrolled. Three had verified hypoglycemia found due to CGM. No patient was below 2 standard deviations in any components of Bayley scales. Median scores were: Cognitive 100, language 86, motor 94. Conclusion: Use of CGM in a rooming-in environment is safe from clinical and neurodevelopmental point of view. Randomized trials are needed to evaluate superiority in longer term outcomes.
Related Concept Videos
Hypoglycemia and Glucagon
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...

